These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22932224)

  • 21. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y; Feng SS
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.
    Mert O; Lai SK; Ensign L; Yang M; Wang YY; Wood J; Hanes J
    J Control Release; 2012 Feb; 157(3):455-60. PubMed ID: 21911015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as polymeric emulsifier for the preparation of biodegradable nanoparticles.
    Gaucher G; Poreba M; Ravenelle F; Leroux JC
    J Pharm Sci; 2007 Jul; 96(7):1763-75. PubMed ID: 17387697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).
    Wu L; Tang C; Yin C
    Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
    Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
    De Campos AM; Sánchez A; Gref R; Calvo P; Alonso MJ
    Eur J Pharm Sci; 2003 Sep; 20(1):73-81. PubMed ID: 13678795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
    Calvo P; Gouritin B; Chacun H; Desmaële D; D'Angelo J; Noel JP; Georgin D; Fattal E; Andreux JP; Couvreur P
    Pharm Res; 2001 Aug; 18(8):1157-66. PubMed ID: 11587488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
    Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
    J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphiphilic poly{[alpha-maleic anhydride-omega-methoxy-poly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery.
    Xing J; Deng L; Li J; Dong A
    Int J Nanomedicine; 2009; 4():227-32. PubMed ID: 19918369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes.
    Pang Z; Gao H; Yu Y; Chen J; Guo L; Ren J; Wen Z; Su J; Jiang X
    Int J Pharm; 2011 Aug; 415(1-2):284-92. PubMed ID: 21651966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
    Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
    J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
    Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
    Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
    Garcia-Fuentes M; Prego C; Torres D; Alonso MJ
    Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.
    Trapani A; Denora N; Iacobellis G; Sitterberg J; Bakowsky U; Kissel T
    AAPS PharmSciTech; 2011 Dec; 12(4):1302-11. PubMed ID: 21948322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.